Detalles de la búsqueda
1.
Hepatotoxicity as dose-limiting toxicity of the combination of bosutinib and atezolizumab in patients with chronic myeloid leukemia. Results of the ZEROLMC study.
Ann Hematol
; 2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38568260
2.
High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance.
Haematologica
; 104(11): 2249-2257, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30890600
3.
Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML.
Blood Adv
; 6(17): 5132-5145, 2022 09 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35728048
4.
Hematopoietic cell transplantation during COVID-19 pandemic: experience from a tertiary hospital in Madrid.
Expert Rev Hematol
; 14(1): 1-5, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33280467
Resultados
1 -
4
de 4
1
Próxima >
>>